Model Number 8637-40 |
Device Problems
Premature Elective Replacement Indicator (1483); Pumping Stopped (1503)
|
Patient Problem
Therapeutic Response, Decreased (2271)
|
Event Date 10/13/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a patient via a manufacturer¿s representative (rep) regarding the patient¿s implantable drug infusion device.The drugs being delivered were bupivacaine and morphine at a dose of 5 mg/day with unknown concentrations.The reason for use was non-malignant name and failed back surgery syndrome.It was reported that the patient presented to the clinic on (b)(6) 2018.Interrogation of the device was performed and a motor stall was seen.It was unknown if the patient recently had an mri.The caller reported multiple motor stalls and recoveries per the event logs beginning (b)(6) 2018 with the last stall occurring on (b)(6) 2018.Running the logs showed 3 separate motor stalls and the third was without recovery.Over the course of the weekend the patient went through withdrawal and was presented to the emergency department.A consult was scheduled with the neurosurgery department for replacement and surgical intervention was planned.It was unknown if surgical intervention did occur.Environmental/external/patient factors that may have led or contributed to the issue included a compounded drug being used.Troubleshooting with the caller consisted of reviewing pertinent information per their inquires including that the patient¿s pump was not affected by the battery fca (field corrective action).The rep had to leave the phone conversation as the doctor was requiring assistance from them.The issue was not resolved at the time of the report, and the patient status was listed as ¿alive ¿ no injury.¿ there were no further complications reported/anticipated.
|
|
Manufacturer Narrative
|
Logs indicate that the drugs being delivered were 20 mg/ml morphine at 0.126 mg/day and 20 mg/ml bupivacaine at 0.126 mg/day.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the healthcare professional (hcp) via rep on 2019-apr-03.The device had been replaced on (b)(6) 2018 due to ¿motor stall ¿ early eri (elective replacement indicator).¿ the product was returned to the manufacturer for analysis.The patient was not in a clinical study and there was no patient death.There were no further complications reported/anticipated.
|
|
Manufacturer Narrative
|
Analysis found there was corrosion/wear/lubrication on the gear train of the pump motor and that there was a stall due to shaft bearing.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|